Viking Therapeutics, Inc. - Common Stock (VKTX)
CUSIP: 92686J106
Q4 2016 13F Holders as of 31 Dec 2016
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 113,177,462
- Total 13F shares
- 636,030
- Share change
- -573,875
- Total reported value
- $757,000
- Price per share
- $1.19
- Number of holders
- 11
- Value change
- -$869,302
- Number of buys
- 7
- Number of sells
- 4
Quarterly Holders Quick Answers
What is CUSIP 92686J106?
CUSIP 92686J106 identifies VKTX - Viking Therapeutics, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 92686J106:
Top shareholders of VKTX - Viking Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Sio Capital Management, LLC |
13F
|
Company |
0.75%
|
849,905
|
$1,191,000 | — | 30 Sep 2016 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.19%
|
220,296
|
$313,000 | — | 30 Sep 2016 | |
| SHEPHERD KAPLAN KROCHUK, LLC |
13F
|
Company |
0.03%
|
33,000
|
$46,000 | — | 30 Sep 2016 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.03%
|
31,264
|
$44,000 | — | 30 Sep 2016 | |
| Virtu KCG Holdings LLC |
13F
|
Company |
0.02%
|
23,578
|
$33,000 | — | 30 Sep 2016 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.02%
|
21,300
|
$30,000 | — | 30 Sep 2016 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.01%
|
16,962
|
$24,000 | — | 30 Sep 2016 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.01%
|
6,250
|
$9,000 | — | 30 Sep 2016 | |
| Acrospire Investment Management LLC |
13F
|
Company |
0%
|
3,700
|
$5,000 | — | 30 Sep 2016 | |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE |
13F
|
Company |
0%
|
1,807
|
$3,000 | — | 30 Sep 2016 | |
| BlackRock Fund Advisors |
13F
|
Company |
0%
|
703
|
$1,000 | — | 30 Sep 2016 | |
| MORGAN STANLEY |
13F
|
Company |
0%
|
612
|
$1,000 | — | 30 Sep 2016 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
528
|
$1,000 | — | 30 Sep 2016 | |
| Advisor Group, Inc. |
13F
|
Company |
0%
|
500
|
$1,000 | — | 30 Sep 2016 |
Institutional Holders of Viking Therapeutics, Inc. - Common Stock (VKTX) as of Q4 2016
As of 31 Dec 2016,
Viking Therapeutics, Inc. - Common Stock (VKTX) was held by
11 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
636,030 shares.
The largest 10 holders included
VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, GRT CAPITAL PARTNERS L.L.C., GEODE CAPITAL MANAGEMENT, LLC, GOLDMAN SACHS GROUP INC, NORTHERN TRUST CORP, MORGAN STANLEY, Acrospire Investment Management LLC, MANUFACTURERS LIFE INSURANCE COMPANY, THE, and REILLY FINANCIAL ADVISORS, LLC.
This page lists
11
institutional shareholders reporting positions in this security
for the Q4 2016 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2016 vs Q3 2016 Across Filers
Q3 2016 holders
13
Q4 2016 holders
11
Holder diff
-2
| Investor | Q3 2016 Shares | Q4 2016 Shares | Share Diff | Share Chg % | Q3 2016 Value $ | Q4 2016 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.